1. "2020"
Formats
  1. Journal Article (2337)
  2. Meeting Abstract (1901)
  3. Review (494)
  4. Editorial (342)
  5. Correspondence (121)
  6. Guidelines (114)
  7. Book Section (99)
  8. Research Letter (95)
  9. Miscellaneous (61)
  10. Conference Paper (33)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2560)
  2. Solid Tumor Oncology Division (1535)
  3. GSK Faculty (1257)
  4. Sloan Kettering Institute Postdocs (1240)
  5. Hematologic Malignancies, Division of (936)
  6. Survivorship Research (930)

More Groups

People
  1. Jorge Reis-Filho (93)
  2. Miguel-Angel Perales (93)
  3. Sergio Giralt (91)
  4. Alexander Drilon (81)
  5. Britta Weigelt (76)
  6. Nadeem Abu-Rustum (71)

More People

Years
  1. 2020 (5599)
Publications
  1. Journal of Clinical Oncology (500)
  2. Blood (212)
  3. Cancer Research (185)
  4. Annals of Oncology (152)
  5. International Journal of Radiation Oncology, Biology, Physics (129)
  6. Laboratory Investigation (116)

More Publications

Publishers
  1. Elsevier Inc. (714)
  2. American Society of Clinical Oncology (548)
  3. Nature Publishing Group (385)
  4. American Association for Cancer Research (357)
  5. Oxford University Press (356)
  6. Springer (342)

More Publishers

Results (5599)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The cancer nurse as primary palliative care agent during COVID-19
    Editorial

    Rosa, W. E.; Finlayson, C. S.; Ferrell, B. R.
    Cancer Nursing (2020)

    Fulltext@MSK | Save
  • Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study
    Journal Article

    Schaffer, M.; Chaturvedi, S.; Davis, C.; de Jong, J.; Aquino, R.; Oki, Y.; Fourneau, N.; Younes, A.; Balasubramanian, S.
    Cancer Treatment and Research Communications (2020)

    Fulltext@MSK | Save
  • Larotrectinib versus prior therapies in tropomyosin receptor kinase fusion cancer: An intra-patient comparative analysis
    Journal Article

    Italiano, A.; Nanda, S.; Briggs, A.; Garcia-Foncillas, J.; Lassen, U.; Vassal, G.; Kummar, S.; van Tilburg, C. M.; Hong, D. S.; Laetsch, T. W.; more...
    Cancers (2020)

    Fulltext@MSK | Save
  • Five year results of Intrabeam intra-operative treatment for breast cancer, from France and not from Target A
    Editorial

    McCormick, B.
    Breast Journal (2020)

    Fulltext@MSK | Save
  • Usefulness of multidetector computed tomography to differentiate between renal cell carcinoma and oncocytoma. A model validation
    Journal Article

    Paño, B.; Soler, A.; Goldman, D. A.; Salvador, R.; Buñesch, L.; Sebastià, C.; Nicolau, C.
    British Journal of Radiology (2020)

    Fulltext@MSK | Save
  • Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
    Journal Article

    Garrido-Castro, A. C.; Saura, C.; Barroso-Sousa, R.; Guo, H.; Ciruelos, E.; Bermejo, B.; Gavilá, J.; Serra, V.; Prat, A.; Paré, L.; more...
    Breast Cancer Research (2020)

    Fulltext@MSK | Save
  • Use of implementation science in tobacco control intervention studies in the USA between 2000 and 2020: A scoping review protocol
    Review

    Selove, R.; Neil-Sztramko, S.; Leng, J.; Walker, P. D.; Salloum, R. G.; Ginossar, T.; Heckman, C.; Scheuermann, T. S.; Combs, T.; Qualls-Hampton, R.; more...
    BMJ Open (2020)

    Fulltext@MSK | Save
  • Hairy cell leukemia expresses programmed death-1
    Research Letter

    Kumar, P.; Gao, Q.; Chan, A.; Lewis, N.; Sigler, A.; Pichardo, J.; Xiao, W.; Roshal, M.; Dogan, A.
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features
    Research Letter

    Argyropoulos, K. V.; Pulitzer, M.; Maura, F.; Mohanty, A.; Mondello, P.; Horwitz, S. M.; Myskowski, P.; Moskowitz, A.; Dogan, A.; Querfeld, C.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Early palliative radiation versus observation for high-risk asymptomatic or minimally symptomatic bone metastases: Study protocol for a randomized controlled trial
    Journal Article

    Rosen, D. B.; Benjamin, C. D.; Yang, J. C.; Doyle, C.; Zhang, Z.; Barker, C. A.; Vaynrub, M.; Yang, T. J.; Gillespie, E. F.
    BMC Cancer (2020)

    Fulltext@MSK | Save